Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2a.

Saved in:
Bibliographic Details
Title: Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2a.
Authors: Itri LM; Department of Clinical Research and Development, Hoffmann-La Roche, Inc., Nutley, NJ 07110., Sherman MI, Palleroni AV, Evans LM, Tran LL, Campion M, Chizzonite R
Source: Journal of interferon research [J Interferon Res] 1989 Sep; Vol. 9 Suppl 1, pp. S9-15.
Publication Type: Clinical Trial; Journal Article; Review
Journal Info: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8100396 Publication Model: Print Cited Medium: Print ISSN: 0197-8357 (Print) Linking ISSN: 01978357 NLM ISO Abbreviation: J Interferon Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0197-8357